Research

Energy balance

Among a subgroup of members on tirzepatide, semaglutide, or with exposure to both, 86.5% of members had at least a 5% reduction in body weight from baseline at 6 months.

These medications are effective for significant weight loss in adherent patients.

StrongSupportsmedium confidence
86.5% of members had at least a 5% reduction in body weight from baseline at 6 months.
Katelyn Meyer et al. · Journal of Managed Care & Specialty Pharmacy · 2026

Why this rating

Based on a retrospective claims-based analysis of a large population.

Source

Real-world 6-month persistence, adherence, and effectiveness of GLP-1 medications for overweight and obesity in a Medicaid population

Katelyn Meyer et al. · Journal of Managed Care & Specialty Pharmacy · 2026

DOI 10.18553/jmcp.2026.32.3.271

cohort · n=7493
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →